Giuseppe Gargiulo

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

Pascal Vranckx, Marco Valgimigli, Lars Eckardt et al. · The Lancet · 2019 · 636 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +13

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

Yasushi Ueki, Sarah Bär, Sylvain Losdat et al. · EuroIntervention · 2020 · 194 citations

Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management

Giuseppe Andò, Bernardo Cortese, Filippo Russo et al. · Journal of the American College of Cardiology · 2017 · 150 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Patient Safety +9

Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding risk

Noé Corpataux, Alessandro Spirito, Felice Gragnano et al. · European Heart Journal · 2020 · 132 citations · Full text